Figure 1b illustrates our orthotopic liver model wherein liver cancer cells were implanted into mouse liver to generate orthotopic liver tumors, followed by treatment with PRL3-zumab for 5 weeks (2 doses per week). Here, PTP4A3 is linked to liver cancer.